Precision Current Deferred Revenue vs Net Debt Analysis

DTIL Stock

USD 9.38 0.34 3.50%

Precision BioSciences financial indicator trend analysis is much more than just breaking down Precision BioSciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Precision BioSciences is a good investment. Please check the relationship between Precision BioSciences Current Deferred Revenue and its Net Debt accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.

Current Deferred Revenue vs Net Debt

Current Deferred Revenue vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Precision BioSciences Current Deferred Revenue account and Net Debt. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Precision BioSciences' Current Deferred Revenue and Net Debt is -0.67. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Net Debt in the same time period over historical financial statements of Precision BioSciences, assuming nothing else is changed. The correlation between historical values of Precision BioSciences' Current Deferred Revenue and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Precision BioSciences are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Current Deferred Revenue i.e., Precision BioSciences' Current Deferred Revenue and Net Debt go up and down completely randomly.

Correlation Coefficient

-0.67

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Most indicators from Precision BioSciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Precision BioSciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.At this time, Precision BioSciences' Sales General And Administrative To Revenue is quite stable compared to the past year. Enterprise Value Over EBITDA is expected to rise to 1.28 this year, although the value of Selling General Administrative will most likely fall to about 29 M.

	2021	2022	2023	2024 (projected)
Gross Profit	115.5M	16.1M	40.5M	33.4M
Total Revenue	115.5M	25.1M	48.7M	35.8M

Gross Profit Total Revenue

Precision BioSciences fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Capital Surpluse	Total Liab	Total Current Assets	Intangible Assets	Property Plant Equipment	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity
Total Assets		0.3	0.81	0.9	-0.55	0.93	-0.76	0.18	0.95	0.61	0.95	0.28	-0.57	0.83	0.61	0.98	0.78	0.78	0.8	0.79	-0.94	0.9	0.67	0.04	0.12	0.88
Other Current Liab	0.3		0.58	0.07	-0.12	0.18	-0.55	-0.26	0.24	0.57	0.24	0.39	-0.73	0.48	0.59	0.28	0.16	0.12	0.12	0.46	-0.03	0.34	0.45	0.21	-0.32	0.51
Total Current Liabilities	0.81	0.58		0.56	-0.54	0.69	-0.94	0.21	0.68	0.67	0.68	0.59	-0.61	0.92	0.82	0.76	0.57	0.73	0.66	0.88	-0.63	0.81	0.7	0.15	0.1	0.97
Total Stockholder Equity	0.9	0.07	0.56		-0.57	0.94	-0.47	0.12	0.82	0.53	0.82	0.06	-0.44	0.58	0.22	0.86	0.86	0.8	0.84	0.56	-0.93	0.85	0.45	-0.31	0.04	0.67
Other Liab	-0.55	-0.12	-0.54	-0.57		-0.64	0.6	-0.09	-0.3	-0.36	-0.3	-0.67	0.42	-0.65	-0.05	-0.4	-0.53	-0.9	-0.9	-0.5	0.39	-0.8	-0.04	0.6	-0.16	-0.6
Net Tangible Assets	0.93	0.18	0.69	0.94	-0.64		-0.68	0.35	0.83	0.44	0.83	0.34	-0.53	0.77	0.36	0.9	0.76	0.85	0.83	0.57	-0.88	0.87	0.38	-0.25	0.21	0.82
Retained Earnings	-0.76	-0.55	-0.94	-0.47	0.6	-0.68		-0.36	-0.63	-0.5	-0.63	-0.75	0.59	-0.99	-0.78	-0.71	-0.44	-0.69	-0.61	-0.75	0.53	-0.77	-0.52	-0.17	-0.28	-0.96
Accounts Payable	0.18	-0.26	0.21	0.12	-0.09	0.35	-0.36		0.15	-0.43	0.15	0.41	0.19	0.38	0.14	0.21	-0.06	0.23	0.02	-0.17	-0.19	0.03	-0.27	0.03	0.76	0.33
Cash	0.95	0.24	0.68	0.82	-0.3	0.83	-0.63	0.15		0.48	1.0	0.1	-0.56	0.69	0.63	0.99	0.63	0.57	0.61	0.71	-0.93	0.72	0.68	0.24	0.06	0.74
Other Assets	0.61	0.57	0.67	0.53	-0.36	0.44	-0.5	-0.43	0.48		0.48	0.02	-0.45	0.48	0.52	0.52	0.76	0.49	0.56	0.79	-0.53	0.74	0.83	0.05	-0.37	0.61
Cash And Short Term Investments	0.95	0.24	0.68	0.82	-0.3	0.83	-0.63	0.15	1.0	0.48		0.1	-0.56	0.69	0.63	0.99	0.63	0.57	0.61	0.71	-0.93	0.72	0.68	0.24	0.06	0.74
Net Receivables	0.28	0.39	0.59	0.06	-0.67	0.34	-0.75	0.41	0.1	0.02	0.1		-0.42	0.73	0.34	0.2	0.0	0.54	0.43	0.33	0.01	0.42	-0.1	-0.17	0.41	0.6
Common Stock Shares Outstanding	-0.57	-0.73	-0.61	-0.44	0.42	-0.53	0.59	0.19	-0.56	-0.45	-0.56	-0.42		-0.6	-0.47	-0.57	-0.22	-0.43	-0.47	-0.55	0.38	-0.55	-0.37	0.04	0.45	-0.61
Capital Surpluse	0.83	0.48	0.92	0.58	-0.65	0.77	-0.99	0.38	0.69	0.48	0.69	0.73	-0.6		0.73	0.78	0.5	0.75	0.69	0.74	-0.61	0.82	0.49	0.1	0.3	0.96
Total Liab	0.61	0.59	0.82	0.22	-0.05	0.36	-0.78	0.14	0.63	0.52	0.63	0.34	-0.47	0.73		0.64	0.25	0.24	0.2	0.77	-0.46	0.45	0.8	0.68	0.08	0.74
Total Current Assets	0.98	0.28	0.76	0.86	-0.4	0.9	-0.71	0.21	0.99	0.52	0.99	0.2	-0.57	0.78	0.64		0.69	0.67	0.68	0.74	-0.94	0.8	0.66	0.16	0.13	0.82
Intangible Assets	0.78	0.16	0.57	0.86	-0.53	0.76	-0.44	-0.06	0.63	0.76	0.63	0.0	-0.22	0.5	0.25	0.69		0.74	0.79	0.63	-0.79	0.85	0.59	-0.26	0.06	0.63
Property Plant Equipment	0.78	0.12	0.73	0.8	-0.9	0.85	-0.69	0.23	0.57	0.49	0.57	0.54	-0.43	0.75	0.24	0.67	0.74		0.97	0.65	-0.69	0.91	0.29	-0.48	0.2	0.79
Property Plant And Equipment Net	0.8	0.12	0.66	0.84	-0.9	0.83	-0.61	0.02	0.61	0.56	0.61	0.43	-0.47	0.69	0.2	0.68	0.79	0.97		0.69	-0.71	0.94	0.35	-0.48	0.08	0.72
Current Deferred Revenue	0.79	0.46	0.88	0.56	-0.5	0.57	-0.75	-0.17	0.71	0.79	0.71	0.33	-0.55	0.74	0.77	0.74	0.63	0.65	0.69		-0.67	0.8	0.85	0.22	-0.1	0.79
Net Debt	-0.94	-0.03	-0.63	-0.93	0.39	-0.88	0.53	-0.19	-0.93	-0.53	-0.93	0.01	0.38	-0.61	-0.46	-0.94	-0.79	-0.69	-0.71	-0.67		-0.78	-0.64	-0.03	-0.08	-0.71
Non Current Assets Total	0.9	0.34	0.81	0.85	-0.8	0.87	-0.77	0.03	0.72	0.74	0.72	0.42	-0.55	0.82	0.45	0.8	0.85	0.91	0.94	0.8	-0.78		0.57	-0.23	0.06	0.86
Non Currrent Assets Other	0.67	0.45	0.7	0.45	-0.04	0.38	-0.52	-0.27	0.68	0.83	0.68	-0.1	-0.37	0.49	0.8	0.66	0.59	0.29	0.35	0.85	-0.64	0.57		0.51	-0.24	0.6
Non Current Liabilities Total	0.04	0.21	0.15	-0.31	0.6	-0.25	-0.17	0.03	0.24	0.05	0.24	-0.17	0.04	0.1	0.68	0.16	-0.26	-0.48	-0.48	0.22	-0.03	-0.23	0.51		0.06	0.06
Other Current Assets	0.12	-0.32	0.1	0.04	-0.16	0.21	-0.28	0.76	0.06	-0.37	0.06	0.41	0.45	0.3	0.08	0.13	0.06	0.2	0.08	-0.1	-0.08	0.06	-0.24	0.06		0.2
Other Stockholder Equity	0.88	0.51	0.97	0.67	-0.6	0.82	-0.96	0.33	0.74	0.61	0.74	0.6	-0.61	0.96	0.74	0.82	0.63	0.79	0.72	0.79	-0.71	0.86	0.6	0.06	0.2

Click cells to compare fundamentals

Precision BioSciences Account Relationship Matchups

Precision BioSciences fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	235.2M	150.2M	211.5M	238.2M	159.8M	179.4M
Other Current Liab	1.6M	9.9M	11.8M	10.2M	11.4M	7.1M
Total Current Liabilities	26.9M	42.8M	36.0M	59.7M	50.0M	34.0M
Total Stockholder Equity	138.3M	44.4M	91.2M	60.4M	18.9M	17.9M
Other Liab	70.0M	54.3M	77.1M	93.1M	83.8M	64.4M
Net Tangible Assets	136.9M	43.1M	89.1M	59.1M	67.9M	52.7M
Retained Earnings	(177.1M)	(286.1M)	(316.7M)	(428.3M)	(489.6M)	(465.1M)
Accounts Payable	2.0M	792K	1.1M	1.2M	3.0M	1.9M
Cash	180.9M	89.8M	143.7M	189.6M	116.7M	134.8M
Other Assets	558K	8.1M	11.5M	9.8M	1.0	0.95
Cash And Short Term Investments	180.9M	89.8M	143.7M	189.6M	116.7M	134.8M
Net Receivables	965K	10M	488K	720K	12.8M	13.4M
Common Stock Shares Outstanding	1.4M	1.7M	2.0M	2.9M	3.8M	3.6M
Capital Surpluse	316.3M	331.5M	408.8M	489.7M	563.2M	591.3M
Total Liab	96.9M	105.7M	120.3M	177.7M	140.9M	129.6M
Total Current Assets	193.7M	105.6M	161.8M	199.1M	136.4M	147.2M
Intangible Assets	1.4M	1.4M	2.0M	1.3M	400K	380K
Property Plant Equipment	39.6M	41.5M	25.2M	20.2M	23.2M	25.0M
Property Plant And Equipment Net	39.6M	41.5M	29.3M	23.2M	14.6M	27.9M
Current Deferred Revenue	16.5M	30.2M	21.2M	46.2M	12.0M	22.1M
Net Debt	(180.9M)	(79.3M)	(134.6M)	(162.5M)	(85.4M)	(89.7M)
Non Current Assets Total	41.6M	44.6M	49.7M	39.1M	23.4M	36.1M
Non Currrent Assets Other	558K	1.7M	4.6M	9.8M	225K	213.8K
Liabilities And Stockholders Equity	235.2M	150.2M	211.5M	238.2M	159.8M	189.5M
Non Current Liabilities Total	70.0M	62.9M	84.4M	118.1M	90.9M	94.4M
Other Current Assets	2.3M	4K	169K	1.3M	6.9M	7.2M
Other Stockholder Equity	315.4M	330.5M	407.8M	488.7M	508.5M	345.3M
Net Invested Capital	138.3M	44.4M	93.6M	82.7M	41.3M	65.0M
Property Plant And Equipment Gross	39.6M	41.5M	53.2M	54.3M	40.1M	40.5M
Net Working Capital	166.7M	62.7M	125.8M	139.4M	86.4M	115.9M
Short Term Debt	6.8M	1.9M	1.8M	2.0M	23.5M	24.7M

Pair Trading with Precision BioSciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Precision BioSciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precision BioSciences will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to Precision BioSciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Precision BioSciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Precision BioSciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Precision BioSciences to buy it.

The correlation of Precision BioSciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Precision BioSciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Precision BioSciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Precision BioSciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Precision BioSciences is a strong investment it is important to analyze Precision BioSciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Precision BioSciences' future performance. For an informed investment choice regarding Precision Stock, refer to the following important reports:

How To Invest In Precision

Details

Is Precision Stock a good investment?

Details

What is Precision BioSciences' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.

You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Precision Stock analysis

When running Precision BioSciences' price analysis, check to measure Precision BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precision BioSciences is operating at the current time. Most of Precision BioSciences' value examination focuses on studying past and present price action to predict the probability of Precision BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Precision BioSciences' price. Additionally, you may evaluate how the addition of Precision BioSciences to your portfolios can decrease your overall portfolio volatility.

	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	CEOs Directory Screen CEOs from public companies around the world
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum

Is Precision BioSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(332.12)

Revenue Per Share

12.685

Quarterly Revenue Growth

(0.34)

Return On Assets

(0.14)

Return On Equity

(1.07)

The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Precision Current Deferred Revenue vs Net Debt Analysis

Current Deferred Revenue vs Net Debt

Current Deferred Revenue vs Net Debt Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Net Debt

Precision BioSciences fundamental ratios Correlations

Precision BioSciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Precision BioSciences fundamental ratios Accounts

Pair Trading with Precision BioSciences

Complementary Tools for Precision Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash And Short Term Investments
Total Current Assets	+ 0.98	Total Assets
Other Stockholder Equity	+ 0.97	Total Current Liabilities
Property Plant And Equipment Net	+ 0.97	Property Plant Equipment

Capital Surpluse	- 0.99	Retained Earnings
Other Stockholder Equity	- 0.96	Retained Earnings
Net Debt	- 0.94	Total Current Assets
Retained Earnings	- 0.94	Total Current Liabilities
Net Debt	- 0.94	Total Assets
Net Debt	- 0.93	Cash And Short Term Investments